#CNATM
Teamed up with with SFBTRR267 & CNATM for the workshop "Women & Career". From strategic networking to balancing family and academia, we ditched fixed blueprints to focus on what truly matters to early-career researchers.

That was our first NUCLEATE workshop for PhDs & postdocs. More coming soon! 🚀
September 22, 2026 at 2:36 PM
Am 18.9. findet in der BAdW die CNATM Karrieremesse statt, v.a. für Studis und PostDocs aus #Chemie, #Medizin und #Biologie interessant. Noch unschlüssig, wie es nach dem Studium weitergehen soll? Hier findet ihr Ideen von Biotechindustrie über Forschung bis eigenes Start-up!

tiny.badw.de/ze6ld0
August 7, 2025 at 7:03 AM
🧬 Ein Team um Olivia Merkel, Lehrstuhlinhaberin für Drug Delivery an der #LMU und Co-Sprecherin des Cluster for Nucleic Acid Therapeutics Munich CNATM, kombiniert erstmals Machine Learning und #Molekulardynamik zur Entdeckung neuartiger RNA-Transportmaterialien. www.lmu.de/de/newsroom/...
Neue Plattform zur Entwicklung therapeutischer RNA-Trägersysteme
LMU-Forschende kombinieren erstmals Machine Learning und Molekulardynamik zur Entdeckung neuartiger RNA-Transportmaterialien.
www.lmu.de
December 2, 2025 at 10:28 AM
13.04.–16.04.26: Jetzt noch für die TFmed 2026 anmelden – organisiert durch die BMFTR-geförderten Clusters4Future-Initiativen PROXIDRUGS, curATime und CNATM.
🔗https://www.tfmed.de/
@goetheuni.bsky.social , @unimainz.bsky.social @tuda.bsky.social
Therapeutic Frontiers in Medicine Conference | TFmed conference
Therapeutic Frontiers in Medicine TFMed 2026 is the premier international conference for Translational Medicine, bringing together leading scientists, clinicians, and industry innovators to advance t...
www.tfmed.de
January 26, 2026 at 1:22 PM
Grünenthal Joins Munich's Nucleic Acid Therapeutics Innovation Hub to Enhance Genetic Medicine#Germany#Munich#Grünenthal#Nucleic_Acid#CNATM
Grünenthal Joins Munich's Nucleic Acid Therapeutics Innovation Hub to Enhance Genetic Medicine
Grünenthal has strengthened its capabilities in genetic medicine by joining the Munich Cluster for Nucleic Acid Therapeutics, aiming to innovate therapeutic solutions for patients.
third-news.com
July 16, 2026 at 8:24 AM
A new computational platform integrates molecular simulations and machine learning to accelerate the design and optimization of polymer-based RNA nanocarriers for therapeutic applications. doi.org/hbc69k
Computational framework streamlines therapeutic RNA nanocarrier design
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic Acid Therapeutics Munich (CNATM) has developed the first integrated platform that combines molecular dynamics (MD) simulations and machine learning (ML) to identify new polymeric materials for therapeutic RNA delivery.
phys.org
December 1, 2025 at 5:14 PM
Voici une vidéo instructive de CNATM Club Audiovisuel Numérique Toulouse Métropole "UN APPORT INDÉNIABLE POUR LE MÉTIER MAIS ...VA-T-ON CONTINUER À ÉCRIRE" ? #technique #media #ia #formation
youtu.be/Zr6MZv7QdSk
UN APPORT INDÉNIABLE POUR LE MÉTIER MAIS ...VA-T-ON CONTINUER À ÉCRIRE ?
YouTube video by CANTM Club Audiovisuel Numérique Toulouse Métropole
youtu.be
February 3, 2025 at 5:37 PM